Related references
Note: Only part of the references are listed.Role of Pathogens in Multiple Sclerosis
Jane E. Libbey et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2014)
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk
K. Strautins et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings
J. O. Virtanen et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
Michael P. Pender et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Multiple Sclerosis: Prospects and Promise
Stephen L. Hauser et al.
ANNALS OF NEUROLOGY (2013)
Multiple sclerosis: autoimmunity and viruses
Matthew F. Cusick et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls
Giuseppe Mameli et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS
Jeffrey A. Cohen et al.
JOURNAL OF NEUROLOGY (2013)
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Aran Groves et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
A regenerative approach to the treatment of multiple sclerosis
Vishal A. Deshmukh et al.
NATURE (2013)
Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice
Xiaojie Wang et al.
NMR IN BIOMEDICINE (2013)
Fingolimod Therapy for Multiple Sclerosis
Mary A. Willis et al.
SEMINARS IN NEUROLOGY (2013)
Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
Stuart M. Cahalan et al.
MOLECULAR PHARMACOLOGY (2013)
Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
Jason G. Cyster et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis
Ernst-Wilhelm Radue et al.
ARCHIVES OF NEUROLOGY (2012)
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
Jens Ingwersen et al.
CLINICAL IMMUNOLOGY (2012)
VARICELLA-ZOSTER VIRUS ENCEPHALITIS AND VASCULOPATHY IN A PATIENT TREATED WITH FINGOLIMOD
John N. Ratchford et al.
NEUROLOGY (2012)
MULTIPLE SCLEROSIS REBOUND FOLLOWING HERPES ZOSTER INFECTION AND SUSPENSION OF FINGOLIMOD
Claus Michael Gross et al.
NEUROLOGY (2012)
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
Ruben Deogracias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis
Pedro J. Gonzalez-Cabrera et al.
MOLECULAR PHARMACOLOGY (2012)
Mechanisms of Fingolimod's Efficacy and Adverse Effects in Multiple Sclerosis
Jeffrey A. Cohen et al.
ANNALS OF NEUROLOGY (2011)
Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite
Cherilyn R. Strader et al.
JOURNAL OF NATURAL PRODUCTS (2011)
The effect of FTY720 in the Theiler's virus model of multiple sclerosis
Libin Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Actions of a picomolar short-acting S1P1 agonist in S1P1-eGFP knock-in mice
Stuart M. Cahalan et al.
NATURE CHEMICAL BIOLOGY (2011)
Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus
Kevin B. Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Fingolimod is a potential novel therapy for multiple sclerosis
Orhan Aktas et al.
NATURE REVIEWS NEUROLOGY (2010)
Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis
Kevin S. Carbajal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Treatment with a sphingosine analog does not alter the outcome of a persistent virus infection
Kevin B. Walsh et al.
VIROLOGY (2010)
CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination
Linda N. Stiles et al.
AUTOIMMUNITY (2009)
FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
Carolyn A. Foster et al.
BRAIN PATHOLOGY (2009)
Oral fingolimod (FTY720) in multiple sclerosis Two-year results of a phase II extension study
P. O'Connor et al.
NEUROLOGY (2009)
Environmental risk factors in multiple sclerosis
M. Pugliatti et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Could Epstein-Barr virus or canine distemper virus cause multiple sclerosis?
John A. Lincoln et al.
NEUROLOGIC CLINICS (2008)
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
Balazs Balatoni et al.
BRAIN RESEARCH BULLETIN (2007)
A specific viral cause of multiple sclerosis: One virus, one disease
Howard L. Lipton et al.
ANNALS OF NEUROLOGY (2007)
T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection
Linda N. Stiles et al.
JOURNAL OF IMMUNOLOGY (2006)
Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS
LN Stiles et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Inhibition of interferon-γ signaling in oligodendroglia delays coronavirus clearance without altering demyelination
JM González et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Coronavirus infection of the central nervous system: host-virus stand-off
CC Bergmann et al.
NATURE REVIEWS MICROBIOLOGY (2006)
Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation
L McCoy et al.
AUTOIMMUNITY (2006)
Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis
WG Glass et al.
JOURNAL OF IMMUNOLOGY (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
M Webb et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis
MO Totoiu et al.
EXPERIMENTAL NEUROLOGY (2004)
Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system
WG Glass et al.
VIROLOGY (2003)
Control of central nervous system viral persistence by neutralizing antibody
C Ramakrishna et al.
JOURNAL OF VIROLOGY (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Inside-out versus outside-in models for virus induced demyelination: axonal damage triggering demyelination
I Tsunoda et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Mechanisms of central nervous system viral persistence: The critical role of antibody and B cells
C Ramakrishna et al.
JOURNAL OF IMMUNOLOGY (2002)
MHV infection of the CNS: Mechanisms of immune-mediated control
NW Marten et al.
VIRAL IMMUNOLOGY (2001)
CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination
GF Wu et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
